ETF Foundry
DRAFT — HYPOTHETICAL MODEL PORTFOLIO — NOT A REGISTERED FUND, NOT AN OFFER TO SELL SECURITIES, NOT INVESTMENT ADVICE.
momentum factor · long-only model fund

Foundry IntMom Factor ETF

ETF Foundry Research (hypothetical) · rebalanced monthly

FINTHYPOTHETICAL MODEL
Since ’99
+114%
Expense Ratio
0.29%
placeholder
Holdings
296
cap-weighted
Inception
Nov 2021
placeholder
Full Sharpe
0.24
Ann. Return (LS)
5.7%
Ann. Volatility
23.8%
Max Drawdown
-63.0%
Test Sharpe ’19–26
0.08
Test FF5 α (ann.)
0.8%
vs Fama-French 5
Test FF5 α t-stat
0.09
not significant
Monthly turnover
41%
of the long leg, per rebalance
Cumulative return (LS)
114%
over 331 months
This fund holds the long leg only
Long leg Sharpe
0.58
what this fund holds
Long leg ann. return
14.7%
buyable, long-only
Long-short Sharpe
0.24
requires shorting
Bottom bucket ann. return
9.1%
the basket shorted

Every other metric on this page is the long-shortstrategy, which needs a short book. This fund is the long leg alone, so these are the figures for what it actually holds. The bottom-bucket number is that basket’s own return — not short P&L.

Hypothetical growth of $1 — long-short backtest

Gross of the placeholder expense ratio and trading costs · not investor results

331 months

Holdings

Every constituent of the long leg — sort, search or filter by sector

296 of 296 · 100.0% of book
TickerCompanySectorMarket capWeight
1GOOGL
ALPHABET INCCommunication Services$4.20T
49.29%
2MU
MICRON TECHNOLOGY INCTechnology$958.80B
11.25%
3INTC
INTEL CORPTechnology$477.67B
5.60%
4LRCX
LAM RESEARCH CORPTechnology$391.80B
4.60%
5SNDK
SANDISK CORPTechnology$200.63B
2.35%
6STX
SEAGATE TECHNOLOGY HOLDINGS PLCTechnology$176.62B
2.07%
7WDC
WESTERN DIGITAL CORPTechnology$164.49B
1.93%
8APP
APPLOVIN CORPTechnology$142.62B
1.67%
9SCCO
SOUTHERN COPPER CORPBasic Materials$142.48B
1.67%
10NEM
NEWMONT CORPBasic Materials$95.76B
1.12%
11GM
GENERAL MOTORS COConsumer Cyclical$68.59B
0.80%
12WBD
WARNER BROS DISCOVERY INCCommunication Services$67.37B
0.79%
13BE
BLOOM ENERGY CORPIndustrials$61.14B
0.72%
14LITE
LUMENTUM HOLDINGS INCTechnology$57.01B
0.67%
15COHR
COHERENT CORPTechnology$54.31B
0.64%
16CIEN
CIENA CORPTechnology$53.00B
0.62%
17TER
TERADYNE INCTechnology$50.46B
0.59%
18RVMD
REVOLUTION MEDICINES INCHealthcare$39.58B
0.46%
19NTRA
NATERA INCHealthcare$38.87B
0.46%
20TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTDHealthcare$37.30B
0.44%
21CNC
CENTENE CORPHealthcare$32.81B
0.38%
22EXPE
EXPEDIA GROUP INCIndustrials$32.26B
0.38%
23ECHO
ECHO GLOBAL LOGISTICS INCIndustrials$26.66B
0.31%
24MDB
MONGODB INCTechnology$25.12B
0.29%
25ROIV
ROIVANT SCIENCES LTDHealthcare$24.82B
0.29%
26INSM
INSMED INCHealthcare$23.48B
0.28%
27UTHR
UNITED THERAPEUTICS CORPHealthcare$22.74B
0.27%
28RIVN
RIVIAN AUTOMOTIVE INCConsumer Cyclical$22.00B
0.26%
29MKSI
MKS INCTechnology$21.93B
0.26%
30GH
GUARDANT HEALTH INCHealthcare$20.67B
0.24%
31BBIO
BRIDGEBIO PHARMA INCHealthcare$15.94B
0.19%
32AMKR
AMKOR TECHNOLOGY INCTechnology$15.60B
0.18%
33CDE
COEUR MINING INCBasic Materials$14.85B
0.17%
34SITM
SITIME CORPTechnology$14.65B
0.17%
35ALB
ALBEMARLE CORPBasic Materials$14.24B
0.17%
36ONTO
ONTO INNOVATION INCTechnology$13.92B
0.16%
37BTSG
BRIGHTSPRING HEALTH SERVICES INCHealthcare$13.71B
0.16%
38ELAN
ELANCO ANIMAL HEALTH INCHealthcare$12.90B
0.15%
39MDGL
MADRIGAL PHARMACEUTICALS INCHealthcare$12.76B
0.15%
40DOCN
DIGITALOCEAN HOLDINGS INCTechnology$12.41B
0.15%
41AXSM
AXSOME THERAPEUTICS INCHealthcare$11.84B
0.14%
42W
WAYFAIR INCConsumer Cyclical$11.79B
0.14%
43AA
ALCOA CORPBasic Materials$11.61B
0.14%
44VICR
VICOR CORPTechnology$10.83B
0.13%
45ARWR
ARROWHEAD PHARMACEUTICALS INCHealthcare$10.47B
0.12%
46KRYS
KRYSTAL BIOTECH INCHealthcare$10.46B
0.12%
47GMED
GLOBUS MEDICAL INCHealthcare$10.45B
0.12%
48HUT
HUT 8 CORPFinancial Services$10.30B
0.12%
49GSAT
GLOBALSTAR INCCommunication Services$10.20B
0.12%
50APGE
APOGEE THERAPEUTICS INCHealthcare$10.10B
0.12%
51CYTK
CYTOKINETICS INCHealthcare$9.98B
0.12%
52VSAT
VIASAT INCTechnology$9.76B
0.11%
53HL
HECLA MINING COBasic Materials$9.61B
0.11%
54KYMR
KYMERA THERAPEUTICS INCHealthcare$9.52B
0.11%
55PTGX
PROTAGONIST THERAPEUTICS INCHealthcare$9.06B
0.11%
56WULF
TERAWULF INCFinancial Services$9.00B
0.11%
57IONS
IONIS PHARMACEUTICALS INCHealthcare$8.99B
0.11%
58VIAV
VIAVI SOLUTIONS INCTechnology$8.93B
0.10%
59CRNX
CRINETICS PHARMACEUTICALS INCHealthcare$8.84B
0.10%
60PRAX
PRAXIS PRECISION MEDICINES INCHealthcare$8.77B
0.10%
61SYRE
SPYRE THERAPEUTICS INCHealthcare$8.70B
0.10%
62IMVT
IMMUNOVANT INCHealthcare$8.27B
0.10%
63FORM
FORMFACTOR INCTechnology$8.23B
0.10%
64PL
PLANET LABS PBCIndustrials$8.01B
0.09%
65APLD
APPLIED DIGITAL CORPFinancial Services$7.37B
0.09%
66PACS
PACS GROUP INCHealthcare$7.30B
0.09%
67CIFR
CIPHER DIGITAL INCFinancial Services$7.18B
0.08%
68ENS
ENERSYSIndustrials$7.18B
0.08%
69LQDA
LIQUIDIA CORPHealthcare$7.11B
0.08%
70COGT
COGENT BIOSCIENCES INCHealthcare$6.68B
0.08%
71VFC
V F CORPConsumer Cyclical$6.65B
0.08%
72VSXY
VICTORIA'S SECRET & COConsumer Cyclical$6.47B
0.08%
73LUMN
LUMEN TECHNOLOGIES INCCommunication Services$6.47B
0.08%
74CGON
CG ONCOLOGY INCHealthcare$6.34B
0.07%
75M
MACY'S INCConsumer Cyclical$6.23B
0.07%
76ERAS
ERASCA INCHealthcare$5.96B
0.07%
77DNTH
DIANTHUS THERAPEUTICS INCHealthcare$5.77B
0.07%
78AMRX
AMNEAL PHARMACEUTICALS INCHealthcare$5.69B
0.07%
79PRM
PERIMETER SOLUTIONS INCBasic Materials$5.61B
0.07%
80ORKA
ORUKA THERAPEUTICS INCHealthcare$5.59B
0.07%
81SSRM
SSR MINING INCBasic Materials$5.31B
0.06%
82TVTX
TRAVERE THERAPEUTICS INCHealthcare$5.27B
0.06%
83XMTR
XOMETRY INCIndustrials$5.18B
0.06%
84LMND
LEMONADE INCFinancial Services$5.16B
0.06%
85SPHR
SPHERE ENTERTAINMENT COCommunication Services$5.10B
0.06%
86SHC
SOTERA HEALTH COHealthcare$5.06B
0.06%
87VCYT
VERACYTE INCHealthcare$4.72B
0.06%
88LFST
LIFESTANCE HEALTH GROUP INCHealthcare$4.49B
0.05%
89CELC
CELCUITY INCHealthcare$4.31B
0.05%
90EWTX
EDGEWISE THERAPEUTICS INCHealthcare$4.28B
0.05%
91HCC
WARRIOR MET COAL INCBasic Materials$4.17B
0.05%
92CENX
CENTURY ALUMINUM COBasic Materials$4.11B
0.05%
93LION
LIONSGATE STUDIOS CORPCommunication Services$4.03B
0.05%
94DYN
DYNE THERAPEUTICS INCHealthcare$3.92B
0.05%
95LASR
NLIGHT INCTechnology$3.91B
0.05%
96RLAY
RELAY THERAPEUTICS INCHealthcare$3.81B
0.04%
97ADPT
ADAPTIVE BIOTECHNOLOGIES CORPHealthcare$3.67B
0.04%
98ALMS
ALUMIS INCHealthcare$3.65B
0.04%
99ARQT
ARCUTIS BIOTHERAPEUTICS INCHealthcare$3.56B
0.04%
100GPCR
STRUCTURE THERAPEUTICS INCHealthcare$3.45B
0.04%
101RCUS
ARCUS BIOSCIENCES INCHealthcare$3.44B
0.04%
102HP
HELMERICH & PAYNE INCEnergy$3.41B
0.04%
103ONDS
ONDAS INCTechnology$3.23B
0.04%
104SHOO
STEVEN MADDEN LTDConsumer Cyclical$3.17B
0.04%
105GRAL
GRAIL INCHealthcare$3.12B
0.04%
106AXTI
AXT INCTechnology$3.00B
0.04%
107MBX
MBX BIOSCIENCES INCHealthcare$2.99B
0.04%
108UUUU
ENERGY FUELS INCBasic Materials$2.87B
0.03%
109AEO
AMERICAN EAGLE OUTFITTERS INCConsumer Cyclical$2.85B
0.03%
110RUN
SUNRUN INCTechnology$2.83B
0.03%
111VERA
VERA THERAPEUTICS INCHealthcare$2.76B
0.03%
112VISN
VISTANCE NETWORKS INCTechnology$2.74B
0.03%
113BTU
PEABODY ENERGY CORPBasic Materials$2.73B
0.03%
114ESTA
ESTABLISHMENT LABS HOLDINGS INCHealthcare$2.72B
0.03%
115TRVI
TREVI THERAPEUTICS INCHealthcare$2.71B
0.03%
116KOD
KODIAK SCIENCES INCHealthcare$2.67B
0.03%
117FLNC
FLUENCE ENERGY INCUtilities$2.59B
0.03%
118TARS
TARSUS PHARMACEUTICALS INCHealthcare$2.58B
0.03%
119QURE
UNIQURE NVHealthcare$2.54B
0.03%
120IMNM
IMMUNOME INCHealthcare$2.53B
0.03%
121SLS
SELLAS LIFE SCIENCES GROUP INCHealthcare$2.45B
0.03%
122NRIX
NURIX THERAPEUTICS INCHealthcare$2.40B
0.03%
123NKTR
NEKTAR THERAPEUTICSHealthcare$2.31B
0.03%
124NG
NOVAGOLD RESOURCES INCBasic Materials$2.27B
0.03%
125PVLA
PALVELLA THERAPEUTICS INCHealthcare$2.26B
0.03%
126MLYS
MINERALYS THERAPEUTICS INCHealthcare$2.23B
0.03%
127SION
SIONNA THERAPEUTICS INCHealthcare$2.23B
0.03%
128MD
PEDIATRIX MEDICAL GROUP INCHealthcare$2.15B
0.03%
129AXGN
AXOGEN INCHealthcare$2.12B
0.02%
130PPTA
PERPETUA RESOURCES CORPBasic Materials$2.11B
0.02%
131AVAH
AVEANNA HEALTHCARE HOLDINGS INCHealthcare$2.11B
0.02%
132GLUE
MONTE ROSA THERAPEUTICS INCHealthcare$2.07B
0.02%
133AUPH
AURINIA PHARMACEUTICALS INCHealthcare$2.05B
0.02%
134CDNA
CAREDX INCHealthcare$2.05B
0.02%
135RAPP
RAPPORT THERAPEUTICS INCHealthcare$2.04B
0.02%
136NUVB
NUVATION BIO INCHealthcare$2.03B
0.02%
137SNDX
SYNDAX PHARMACEUTICALS INCHealthcare$2.02B
0.02%
138INFQ
INFLEQTION INCTechnology$1.98B
0.02%
139KSS
KOHLS CORPConsumer Cyclical$1.96B
0.02%
140DMRA
DAMORA THERAPEUTICS INCHealthcare$1.94B
0.02%
141TYRA
TYRA BIOSCIENCES INCHealthcare$1.91B
0.02%
142NEO
NEOGENOMICS INCHealthcare$1.90B
0.02%
143NGL
NGL ENERGY PARTNERS LPEnergy$1.89B
0.02%
144ZBIO
ZENAS BIOPHARMA INCHealthcare$1.86B
0.02%
145ALGT
ALLEGIANT TRAVEL COIndustrials$1.86B
0.02%
146VRDN
VIRIDIAN THERAPEUTICS INCHealthcare$1.86B
0.02%
147AMR
ALPHA METALLURGICAL RESOURCES INCBasic Materials$1.83B
0.02%
148STOK
STOKE THERAPEUTICS INCHealthcare$1.81B
0.02%
149SONO
SONOS INCTechnology$1.80B
0.02%
150ZYME
ZYMEWORKS INCHealthcare$1.77B
0.02%
151HYMC
HYCROFT MINING HOLDING CORPBasic Materials$1.74B
0.02%
152HROW
HARROW INCHealthcare$1.74B
0.02%
153BFLY
BUTTERFLY NETWORK INCHealthcare$1.73B
0.02%
154SHLS
SHOALS TECHNOLOGIES GROUP INCTechnology$1.73B
0.02%
155FIGS
FIGS INCConsumer Cyclical$1.72B
0.02%
156TSHA
TAYSHA GENE THERAPIES INCHealthcare$1.71B
0.02%
157PLAB
PHOTRONICS INCTechnology$1.70B
0.02%
158ANAB
ANAPTYSBIO INCHealthcare$1.69B
0.02%
159FTRE
FORTREA HOLDINGS INCHealthcare$1.68B
0.02%
160CMPS
COMPASS PATHWAYS PLCHealthcare$1.67B
0.02%
161TE
T1 ENERGY INCIndustrials$1.63B
0.02%
162PUMP
PROPETRO HOLDING CORPEnergy$1.59B
0.02%
163INNV
INNOVAGE HOLDING CORPHealthcare$1.56B
0.02%
164MAZE
MAZE THERAPEUTICS INCHealthcare$1.56B
0.02%
165SKYT
SKYWATER TECHNOLOGY INCTechnology$1.54B
0.02%
166XERS
XERIS BIOPHARMA HOLDINGS INCHealthcare$1.52B
0.02%
167SEPN
SEPTERNA INCHealthcare$1.51B
0.02%
168AIP
ARTERIS INCTechnology$1.43B
0.02%
169KMTS
KESTRA MEDICAL TECHNOLOGIES LTDHealthcare$1.43B
0.02%
170GCT
GIGACLOUD TECHNOLOGY INCTechnology$1.40B
0.02%
171REAL
THEREALREAL INCConsumer Cyclical$1.35B
0.02%
172BW
BABCOCK & WILCOX ENTERPRISES INCIndustrials$1.35B
0.02%
173FBYD
FALCON'S BEYOND GLOBAL INCIndustrials$1.35B
0.02%
174ATEC
ALPHATEC HOLDINGS INCHealthcare$1.31B
0.02%
175XNCR
XENCOR INCHealthcare$1.30B
0.02%
176IE
IVANHOE ELECTRIC INCBasic Materials$1.29B
0.02%
177INBX
INHIBRX BIOSCIENCES INCHealthcare$1.28B
0.02%
178TTI
TETRA TECHNOLOGIES INCEnergy$1.25B
0.01%
179CRVS
CORVUS PHARMACEUTICALS INCHealthcare$1.25B
0.01%
180NBR
NABORS INDUSTRIES LTDEnergy$1.24B
0.01%
181IRMD
IRADIMED CORPHealthcare$1.24B
0.01%
182AMRC
AMERESCO INCIndustrials$1.22B
0.01%
183DRTS
ALPHA TAU MEDICAL LTDHealthcare$1.19B
0.01%
184COLL
COLLEGIUM PHARMACEUTICAL INCHealthcare$1.17B
0.01%
185SVRA
SAVARA INCHealthcare$1.13B
0.01%
186CAPR
CAPRICOR THERAPEUTICS INCHealthcare$1.13B
0.01%
187NUTX
NUTEX HEALTH INCHealthcare$1.12B
0.01%
188WVE
WAVE LIFE SCIENCES LTDHealthcare$1.12B
0.01%
189UPWK
UPWORK INCIndustrials$1.12B
0.01%
190EYPT
EYEPOINT INCHealthcare$1.12B
0.01%
191RHLD
RESOLUTE HOLDINGS MANAGEMENT INCIndustrials$1.10B
0.01%
192GOLD
GOLDCOM INCFinancial Services$1.09B
0.01%
193JBIO
JADE BIOSCIENCES INCHealthcare$1.03B
0.01%
194AVTX
AVALO THERAPEUTICS INCHealthcare$1.02B
0.01%
195BIOA
BIOAGE LABS INCHealthcare$1.01B
0.01%
196OLMA
OLEMA PHARMACEUTICALS INCHealthcare$1.00B
0.01%
197FBRX
FORTE BIOSCIENCES INCHealthcare$1.00B
0.01%
198ABX
ABACUS GLOBAL MANAGEMENT INCFinancial Services$994M
0.01%
199MUX
MCEWEN INCBasic Materials$978M
0.01%
200ANRO
ALTO NEUROSCIENCE INCHealthcare$967M
0.01%
201KURA
KURA ONCOLOGY INCHealthcare$964M
0.01%
202ANNX
ANNEXON INCHealthcare$950M
0.01%
203TBPH
THERAVANCE BIOPHARMA INCHealthcare$873M
0.01%
204PHAT
PHATHOM PHARMACEUTICALS INCHealthcare$873M
0.01%
205AVR
ANTERIS TECHNOLOGIES GLOBAL CORPHealthcare$823M
0.01%
206UAMY
UNITED STATES ANTIMONY CORPBasic Materials$809M
0.01%
207ACRS
ACLARIS THERAPEUTICS INCHealthcare$793M
0.01%
208DSGN
DESIGN THERAPEUTICS INCHealthcare$785M
0.01%
209BBNX
BETA BIONICS INCHealthcare$771M
0.01%
210RIGL
RIGEL PHARMACEUTICALS INCHealthcare$750M
0.01%
211MNPR
MONOPAR THERAPEUTICSHealthcare$744M
0.01%
212CSTL
CASTLE BIOSCIENCES INCHealthcare$733M
0.01%
213CLYM
CLIMB BIO INCHealthcare$727M
0.01%
214OMER
OMEROS CORPHealthcare$701M
0.01%
215MAMA
MAMA'S CREATIONS INCConsumer Defensive$700M
0.01%
216BALY
BALLY'S CORPConsumer Cyclical$688M
0.01%
217LPTH
LIGHTPATH TECHNOLOGIES INCTechnology$657M
0.01%
218FEIM
FREQUENCY ELECTRONICS INCTechnology$650M
0.01%
219TCMD
TACTILE SYSTEMS TECHNOLOGY INCHealthcare$648M
0.01%
220ACHV
ACHIEVE LIFE SCIENCES INCHealthcare$644M
0.01%
221NVRI
ENVIRI CORPIndustrials$643M
0.01%
222AENT
ALLIANCE ENTERTAINMENT HOLDING CORPCommunication Services$641M
0.01%
223FET
FORUM ENERGY TECHNOLOGIES INCEnergy$593M
0.01%
224MYGN
MYRIAD GENETICS INCHealthcare$584M
0.01%
225STTK
SHATTUCK LABS INCHealthcare$577M
0.01%
226FDMT
4D MOLECULAR THERAPEUTICS INCHealthcare$575M
0.01%
227FLGT
FULGENT GENETICS INCHealthcare$573M
0.01%
228IMMX
IMMIX BIOPHARMA INCHealthcare$558M
0.01%
229RYAM
RAYONIER ADVANCED MATERIALS INCBasic Materials$555M
0.01%
230RLMD
RELMADA THERAPEUTICS INCHealthcare$550M
0.01%
231NPCE
NEUROPACE INCHealthcare$548M
0.01%
232ELA
ENVELA CORPConsumer Cyclical$547M
0.01%
233XMAX
XMAX INCConsumer Cyclical$541M
0.01%
234CTNM
CONTINEUM THERAPEUTICS INCHealthcare$532M
0.01%
235ZURA
ZURA BIO LTDHealthcare$518M
0.01%
236ARVN
ARVINAS INCHealthcare$517M
0.01%
237RGNX
REGENXBIO INCHealthcare$511M
0.01%
238MG
MISTRAS GROUP INCIndustrials$500M
0.01%
239AMCX
AMC GLOBAL MEDIA INCCommunication Services$461M
0.01%
240KYTX
KYVERNA THERAPEUTICS INCHealthcare$453M
0.01%
241ALTO
ALTO INGREDIENTS INCBasic Materials$453M
0.01%
242IDR
IDAHO STRATEGIC RESOURCES INCBasic Materials$449M
0.01%
243VREX
VAREX IMAGING CORPHealthcare$444M
0.01%
244MATV
MATIV HOLDINGS INCBasic Materials$442M
0.01%
245BETR
BETTER HOME & FINANCE HOLDING COFinancial Services$442M
0.01%
246PBYI
PUMA BIOTECHNOLOGY INCHealthcare$434M
0.01%
247ASMB
ASSEMBLY BIOSCIENCES INCHealthcare$426M
0.00%
248TENX
TENAX THERAPEUTICS INCHealthcare$420M
0.00%
249IMXI
INTERNATIONAL MONEY EXPRESS INCTechnology$404M
0.00%
250ENTA
ENANTA PHARMACEUTICALS INCHealthcare$400M
0.00%
251EBS
EMERGENT BIOSOLUTIONS INCHealthcare$394M
0.00%
252DMAC
DIAMEDICA THERAPEUTICS INCHealthcare$393M
0.00%
253UPB
UPSTREAM BIO INCHealthcare$382M
0.00%
254NATR
NATURES SUNSHINE PRODUCTS INCConsumer Defensive$359M
0.00%
255ELMD
ELECTROMED INCHealthcare$349M
0.00%
256MRAM
EVERSPIN TECHNOLOGIES INCTechnology$341M
0.00%
257CV
CAPSOVISION INCHealthcare$335M
0.00%
258VNDA
VANDA PHARMACEUTICALS INCHealthcare$327M
0.00%
259TWIN
TWIN DISC INCIndustrials$326M
0.00%
260VELO
VELO3D INCTechnology$316M
0.00%
261ZUMZ
ZUMIEZ INCConsumer Cyclical$315M
0.00%
262LYEL
LYELL IMMUNOPHARMA INCHealthcare$311M
0.00%
263BKTI
BK TECHNOLOGIES CORPTechnology$307M
0.00%
264OPTX
SYNTEC OPTICS HOLDINGS INCTechnology$302M
0.00%
265DBI
DESIGNER BRANDS INCConsumer Cyclical$290M
0.00%
266ISBA
ISABELLA BANK CORPFinancial Services$288M
0.00%
267SGHT
SIGHT SCIENCES INCHealthcare$274M
0.00%
268TRDA
ENTRADA THERAPEUTICS INCHealthcare$268M
0.00%
269SRZN
SURROZEN INCHealthcare$255M
0.00%
270ASYS
AMTECH SYSTEMS INCTechnology$242M
0.00%
271DUOT
DUOS TECHNOLOGIES GROUP INCTechnology$241M
0.00%
272GLSI
GREENWICH LIFESCIENCES INCHealthcare$240M
0.00%
273USAU
US GOLD CORPBasic Materials$235M
0.00%
274RDNW
RIDENOW GROUP INCConsumer Cyclical$229M
0.00%
275KPTI
KARYOPHARM THERAPEUTICS INCHealthcare$216M
0.00%
276LTRX
LANTRONIX INCTechnology$207M
0.00%
277FCAP
FIRST CAPITAL INCFinancial Services$205M
0.00%
278FOCL
FOCAL INCHealthcare$204M
0.00%
279EGAN
EGAIN CORPTechnology$180M
0.00%
280INFU
INFUSYSTEM HOLDINGS INCHealthcare$180M
0.00%
281KORE
KORE GROUP HOLDINGS INCCommunication Services$163M
0.00%
282OWLT
OWLET INCHealthcare$162M
0.00%
283AP
AMPCO PITTSBURGH CORPIndustrials$156M
0.00%
284VTVT
VTV THERAPEUTICS INCHealthcare$130M
0.00%
285INSG
INSEEGO CORPTechnology$122M
0.00%
286SPRB
SPRUCE BIOSCIENCES INCHealthcare$120M
0.00%
287WYY
WIDEPOINT CORPTechnology$115M
0.00%
288TRT
TRIO-TECH INTERNATIONALTechnology$103M
0.00%
289CHRN
CHRONOSCALE CORPIndustrials$94M
0.00%
290INTG
INTERGROUP CORPConsumer Cyclical$84M
0.00%
291NRXS
NEURAXIS INCHealthcare$84M
0.00%
292VNCE
VINCE HOLDING CORPConsumer Cyclical$83M
0.00%
293ATRA
ATARA BIOTHERAPEUTICS INCHealthcare$76M
0.00%
294CLNN
CLENE INCHealthcare$76M
0.00%
295BODI
BEACHBODY COMPANY INCCommunication Services$75M
0.00%
296LONA
LEONABIO INCHealthcare$68M
0.00%

Full long-leg book as of July 2026 · cap-weighted · total market cap $8.52T. Hypothetical model holdings — not a registered fund’s portfolio.

Sector Breakdown

10 sectors
Communication Services
50.4%
Technology
34.0%
Healthcare
7.7%
Basic Materials
3.8%
Industrials
1.8%
Consumer Cyclical
1.6%
Financial Services
0.5%
Energy
0.1%
Utilities
0.0%
Consumer Defensive
0.0%

Portfolio Style

Size × value map of the long-leg book

296 classified
Value
Blend
Growth
Large
Mid
Small
2%4
21%23
71%43
<1%22
1%42
1%48
<1%21
<1%35
<1%24

Share of long-leg capital by market cap × book-to-market, using terciles of the 3,283-name universe at July 2026. Rows: Large ≥ $5.2B, Small < $819M. Columns: Value ≥ 0.62, Growth < 0.34 B/M. The dot marks the capital-weighted centroid of the book — 98% toward Large, 86% toward Growth. +3% unclassified (34 missing size/value). Hypothetical holdings — descriptive, not realized P&L.

Tilt over time
Size tilt98% → Large
SmallLarge
Value ↔ growth tilt86% → Growth
ValueGrowth

Capital-weighted centroid of the long leg, December 1998July 2026; the right-hand end is the same value as the box’s dot. 296 names now. Hypothetical holdings — descriptive, not P&L.

Constraint checks

How this book measures against the concentration and liquidity rules — as implemented here

How this book was built

These are UNCONSTRAINED factor sleeves: the construction pipeline sorts on a signal and cap-weights the top bucket, applying no issuer cap, no industry cap and no liquidity screen beyond the universe filter. A failing test therefore reports a constraint that was never applied during construction — it is not a defect in the strategy and not an error in the data. The same signal can be solved subject to these constraints.

Passed
2
Failed
3
Not tested
2
Independent checks
7

7 independent checks plus 1 arithmetically implied by another check (RIC / IRC 851(b)(3)(A) 50% bucket), which is reported separately so the tally cannot overstate scrutiny.

2 of 7 checks could not be tested. Those are neither passes nor failures — they are gaps in what the data can answer, and they are excluded from the passed count above rather than folded into it.

  • With respect to 75% of total assets, no more than 5% may be invested in the securities of any one issuer.

    Required
    >= 75.0%
    Actual
    48.9%
    Margin
    -26.1%
  • No more than 25% of total assets may be invested in the securities of any one issuer.

    Required
    <= 25.0%
    Actual
    49.3%
    Margin
    -24.3%
  • The fund will not concentrate: no more than 25% of total assets in any one industry (excluding government securities and cash items).

    Required
    <= 25.0%
    Actual
    51.8%
    Margin
    -26.8%
Reported separately — arithmetically implied
  • At least 50% of total assets must sit in cash, government securities, other RICs, and other securities limited to 5% of assets and 10% of the issuer's voting securities per issuer.

    Required
    >= 50.0%
    Actual
    48.9%
    Margin
    -1.1%

    Arithmetically entailed by '40 Act 5(b)(1) diversification (75%/5% asset leg) — it cannot fail independently, so it is reported outside the tally rather than counted as a separate check.

Engineering approximation of the cited rules for a DRAFT / HYPOTHETICAL model portfolio that is not a registered fund. This reports whether the portfolio passes the stated test AS IMPLEMENTED HERE; it is not a compliance opinion and is not a statement that any fund is compliant. Real filings need securities counsel.

No verdict sits within 1.0pp of its limit.

Data version — panel=20260719T025334 rows=2239262 asof=202607 issuers=20260719T014536 rates=20260804T224700

Measured on the 2026-07 formation date across 296 holdings (cap-weighted). A different formation date can produce different verdicts.

Derivatives risk (Rule 18f-4)

Whether this long-only book is subject to the VaR tests at all

This assessment describes the long-only book this fund holds — the top bucket only.

Governing rule
Rule 18f-4(c)(4) limited derivatives user exception

This fund QUALIFIES for the limited-derivatives-user exception, so it is excepted from the VaR tests; the ratio below is informational, not the operative limit.

Limited derivatives user exceptionby construction

Rule 18f-4(c)(4): a fund whose derivatives exposure (gross notional, including the value of assets sold short) is <= 10% of net assets is excepted from the VaR tests and the full derivatives risk management program.

Qualifies
Required
<= 10% of net assets
Exposure
0% of net assets
Margin
+10pp

No confidence interval: this follows from portfolio construction, not from an estimate.

Rule 18f-4(c)(2)(i): fund VaR at 99% over 20 trading days must not exceed 200% of the designated reference portfolio's VaR on the same basis.

Informational — does not govern

This fund is excepted from the VaR tests, so the ratio below is context rather than the operative limit. It is shown because it is still a description of the book’s risk, not because it decides anything.

Measured
1.8 (95% CI 1.2-2.5)
x reference VaR
Limit
2.00x
<= 2.00x reference VaR
Fund VaR
17.0%
99% / 20d
Reference
9.6%
FF5 market (mkt)

historical method · 331 monthly observations · about 3.3 in the 99% tail · paired percentile bootstrap over months

Same test, three estimators
historical
1.77x
within
parametric
1.59x
within
cornish fisher
1.70x
within

The estimators agree, which is mild evidence the number isn’t an artefact of one method.

Engineering approximation of SEC Rule 18f-4 for research display. Not a compliance opinion and not a determination that any fund is compliant. Hypothetical model portfolio, not a registered fund.

The research long-short construction behind this factor does not qualify for this exception — a dollar-neutral book counts its full short notional, which is 100% of net assets against a 10% threshold. This product sidesteps that by holding the long leg alone, which is also why the long-leg Sharpe is reported separately throughout the site.

See the long-short verdict on the factor page →

Since publication

Did the edge survive the paper coming out?

published 2012
Before publication (pre-2012)
0.41
Sharpe · 10.3% p.a.
January 1999December 2012 · 168 mo
Since publication
0.04
Sharpe · 0.9% p.a.
January 2013July 2026 · 163 mo
Change in Sharpe−0.37Sharpe weakened since publication91% of the prior annual return given up

Split at January of the year after the factor was published. The post-publication stretch IS genuinely out-of-sample relative to the original study -- the predictor was public by then -- so it speaks to whether the effect survived being known. Nothing is fitted here, so this is performance SINCE PUBLICATION, not validation of a model. Note the 'pre' side is our data before publication (our panel starts ~1999), NOT the study's original in-sample period, which usually ran decades earlier; a decay figure compares before-vs-after within our sample and is not a comparison against the published result.

Consistency across eras

Is this record broadly durable, or one regime?

26 windows
Positive windows
69%
18 of 26 3-year windows made money
Worst window
-0.65
Sharpe, January 2019 – December 2021
January 1999July 2026
Median Sharpe
0.18
Dispersion
0.42
Best window
1.29

3-year rolling windows, stepping 1 year (26 windows). Dispersion is the spread of window Sharpes — higher means the record depends more on which era you look at.

Rules-based factors fit no parameters, so these windows are not out-of-sample tests and do not validate a fitted model. They show whether the factor's record is consistent across eras or driven by one regime.

Returns

Long leg is what this fund holds — long-short is shown for reference

since January 1999
Trailing
PeriodLong legLong-short
1 yearcum.60.6%17.9%
3 yearsp.a.35.7%7.9%
5 yearsp.a.19.6%10.1%
10 yearsp.a.18.9%-2.0%
Since inceptionp.a.12.2%2.8%
Calendar years
YearLong legLong-short
20267 mo44.8%47.0%
202517.6%-18.1%
202437.7%8.0%
202321.0%-29.0%
2022-9.2%73.9%
20210.7%-27.2%
202051.7%-22.8%
201927.4%-1.0%
2018-8.4%5.0%
201720.5%-3.2%
20161.1%-21.0%
2015-2.5%15.3%
201412.9%4.8%
201331.7%-7.9%
201222.9%8.0%
2011-5.0%8.9%
201034.0%23.4%
200928.9%-8.0%
2008-42.8%5.2%
200728.7%38.6%
20067.5%-14.1%
200514.7%24.5%
20048.4%-5.4%
200338.2%-19.1%
2002-9.2%73.3%
2001-12.7%-9.0%
2000-33.8%-44.6%
1999103.5%92.5%

Long leg = the top bucket this fund holds; long-short additionally shorts the bottom bucket and is not achievable in a long-only vehicle. Trailing figures run through July 2026: 1 year is a plain cumulative 12-month return (cum.), 3 years and longer are annualised (p.a.). Years marked with a month count are partial. These match the fact sheet’s tables by construction. Hypothetical backtest, gross of the placeholder expense ratio and trading costs — not investor results.

Fund Facts

Ticker (pseudo)FINT
IssuerETF Foundry Research (hypothetical)
SeriesHypothetical Model Portfolio Series (not a registered trust)
Expense ratio0.29% (placeholder)
Inception2021-11-26 (placeholder)
Listing exchangeNot listed (hypothetical)
CUSIPNot applicable (hypothetical model portfolio)
RebalanceMonthly
Holdings as ofJuly 2026
Total mkt cap (long leg)$8.52T

Methodology

The Foundry IntMom Factor ETF tracks a rules-based model that ranks liquid U.S. common stocks (price > $5, market-cap floor) each month by a IntMom signal and holds the top decile with the highest values. Signals are computed from point-in-time Sharadar fundamentals and total-return prices. The portfolio reconstitutes monthly and is cap-weighted within the long leg.

This is a hypothetical model portfolio for research display only — not a registered fund, not an offer, and not investment advice.

Documents (draft — hypothetical)

Auto-generated from the model’s metrics and current holdings. Every document is labeled DRAFT / hypothetical.

Summary Prospectus

Objective, fees, strategy, and key risks.

View →
Prospectus

Full strategy, model methodology, and risks.

View →
Statement of Additional Information

Policies, construction, and governance.

View →
Fact Sheet

One-page snapshot with top holdings.

View →
Daily Holdings

Full current constituent list.

View →

DRAFT — HYPOTHETICAL MODEL PORTFOLIO — NOT A REGISTERED FUND, NOT AN OFFER TO SELL SECURITIES, NOT INVESTMENT ADVICE.